Krystal Biotech (KRYS) Raw Materials (2023 - 2026)
Krystal Biotech (KRYS) posted quarterly Raw Materials of $15.3 million for Q2 2026, up 8.58% year-over-year from $14.1 million in Q2 2025, and up 0.57% on a QoQ basis from $15.2 million in Q1 2026.
Krystal Biotech (KRYS) Raw Materials (2023 - 2026) Analysis & Trends
Krystal Biotech has reported Raw Materials for 4 years, with the latest figure at $15.3 million in Q2 2026.
- Raw Materials for Q2 2026 came in at $15.3 million, up 8.58% year-over-year; the trailing twelve-month figure through Jun 2026 was $15.3 million (up 8.58% YoY), and the FY2025 annual result was $15.9 million, up 16.86% from the prior year.
- Raw Materials climbed to $15.3 million in Q2 2026, from $15.2 million in the prior quarter.
- Over five years, Raw Materials peaked at $15.9 million in Q4 2025 and troughed at $3.2 million in Q4 2023.
- A 4-year average of $11.4 million and a median of $14.1 million in 2025 frame the typical range for Raw Materials.
- The widest annual swing landed in 2024, when Raw Materials jumped 332.44%; it then gained 0.22% in 2026.
- A 4-year view of Raw Materials shows it stood at $3.2 million in 2023, then jumped by 332.44% to $13.6 million in 2024, then advanced by 16.86% to $15.9 million in 2025, then slipped by 4.26% to $15.3 million in 2026.
- Per Business Quant data, the three most recent Raw Materials figures were $15.3 million in Q2 2026, $15.2 million in Q1 2026, and $15.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Krystal Biotech | 9.83 Bn | 8.99 Bn | 112.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.26 Mn |
| Mar 31, 2026 | 15.17 Mn |
| Dec 31, 2025 | 15.94 Mn |
| Sep 30, 2025 | 14.56 Mn |
| Jun 30, 2025 | 14.05 Mn |
| Mar 31, 2025 | 15.14 Mn |
| Dec 31, 2024 | 13.64 Mn |
| Sep 30, 2024 | 8.98 Mn |
| Jun 30, 2024 | 5.51 Mn |
| Mar 31, 2024 | 4.49 Mn |
| Dec 31, 2023 | 3.15 Mn |